مؤتمر
#523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
| العنوان: | #523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC) |
|---|---|
| المؤلفون: | Banerjee, Susana N, Ring, Kari L, Niewenhuysen, Els Van, Fabbro, Michel, Aghajanian, Carol, Oaknin, Ana, Colombo, Nicoletta, Santin, Alessandro D, Clamp, Andrew R, Moore, Kathleen N, Rose, Peter G, David M, O’Malley, Chon, Hye Sook, Salinas, Erin A, Prendergast, Emily N, Lustgarten, Stephanie, Rodrigues, Manuel, Gennigens, Christine, Monk, Bradley J, Grisham, Rachel N |
| المصدر: | International Journal of Gynecological Cancer, 33, A20-A21 (2023-09); ESGO's 24th European Gynaecological Oncology Congress, 28/09/2023 au 1/10/2023 |
| سنة النشر: | 2023 |
| المجموعة: | University of Liège: ORBi (Open Repository and Bibliography) |
| مصطلحات موضوعية: | Human health sciences, Oncology, Reproductive medicine (gynecology, andrology, obstetrics), Sciences de la santé humaine, Oncologie, Médecine de la reproduction (Gynécologie, andrologie, obstétrique) |
| الوصف: | peer reviewed |
| نوع الوثيقة: | conference object report |
| اللغة: | English |
| تدمد: | 1525-1438 |
| العلاقة: | urn:issn:1525-1438; https://orbi.uliege.be/handle/2268/310283Test; info:hdl:2268/310283 |
| DOI: | 10.1136/ijgc-2023-esgo.29 |
| الإتاحة: | https://doi.org/10.1136/ijgc-2023-esgo.29Test https://orbi.uliege.be/handle/2268/310283Test |
| حقوق: | restricted access ; http://purl.org/coar/access_right/c_16ecTest ; info:eu-repo/semantics/restrictedAccess |
| رقم الانضمام: | edsbas.492D8245 |
| قاعدة البيانات: | BASE |
| تدمد: | 15251438 |
|---|---|
| DOI: | 10.1136/ijgc-2023-esgo.29 |